Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction

    Different types of mastectomies leave different amounts of residual breast tissue. The significance of the residual breast volume (RBV) is not clear. Therefore, we developed an MRI tool that allows to easily a...

    Orit Kaidar-Person, Renata Faermann, Dor Polikar in Breast Cancer Research and Treatment (2024)

  2. Article

    Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines

    David Groheux, Sofia C. Vaz, Gary A. Ulaner in European Journal of Nuclear Medicine and M… (2024)

  3. Article

    Open Access

    Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer

    There is much literature about the role of 2-[18F]FDG PET/CT in patients with breast cancer (BC). However, there exists no international guideline with involvement of the nuclear medicine societies about this sub...

    Sofia C. Vaz, John Patrick Pilkington Woll in European Journal of Nuclear Medicine and M… (2024)

  4. No Access

    Article

    Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future

    In this narrative review, we aim to explore the ability of radiation therapy to eradicate breast cancer regional node metastasis. It is a journey through data of older trials without systemic therapy showing t...

    Orit Kaidar-Person, Trine Tramm, Thorsten Kuehn, Oreste Gentilini in La radiologia medica (2024)

  5. No Access

    Chapter

    Tumour Bed Boost Radiotherapy and Planning Following Partial Breast Reconstruction with Chest Wall Perforator Flaps

    The addition of a tumour bed boost to whole breast irradiation reduces the risk of local recurrence, especially in younger patients with high-risk tumours. The use of tumour bed boost in volume replacement onc...

    Emanuele Garreffa, Philip Poortmans in Pedicled Flaps in Partial Breast Reconstru… (2023)

  6. Article

    Open Access

    The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation

    Recent advances in non-metastatic breast cancer radiation therapy significantly reshaped our views on modern dose and fractionation schedules. Especially the advent of hypofractionation and partial breast irra...

    Icro Meattini, Isabella Palumbo, Carlotta Becherini in La radiologia medica (2022)

  7. No Access

    Chapter

    Management and Workflow

    Radiation therapy (RT) is an important modality of breast cancer patients, regardless of disease stage. In breast cancer, in addition to curative indications, RT is a major modality for palliation or symptom c...

    Jana Jaal, Philip Poortmans, Orit Kaidar-Person in Breast Cancer Radiation Therapy (2022)

  8. No Access

    Chapter

    Non-resectable Patients

    The term non-resectable (inoperable) breast cancer refers to the situation where upfront surgery will not achieve complete excision of all tumours with clear margins. These cancers can present as primary local...

    Einav Gal-Yam, Philip Poortmans in Breast Cancer Radiation Therapy (2022)

  9. No Access

    Chapter

    Available Infrastructure

    Radiation therapy, being an integral part of the treatment of most non-metastatic breast cancer patients and contributing to the management in the metastatic setting (e.g. pain and other symptoms relief, palli...

    Orit Kaidar-Person, Maoz Ben-Ayun, Philip Poortmans in Breast Cancer Radiation Therapy (2022)

  10. No Access

    Chapter

    Target Volume Definition and Delineation Boost/PBI/SIB

    An additional radiation dose (boost) to the primary tumour bed is indicated in case of high-risk breast cancer, while partial breast irradiation (PBI) can be used for low-risk breast cancer patients. For both ...

    Pierfrancesco Franco, Philip Poortmans in Breast Cancer Radiation Therapy (2022)

  11. No Access

    Chapter

    Treatment Planning for Challenging Anatomies

    Treatment planning procedures are set up to obtain optimised dose distributions for the “average” patient. Whereas with individualisation of treatment planning a good compromise between dose objectives for the...

    Sandra Hol, Orit Kaidar-Person, Philip Poortmans in Breast Cancer Radiation Therapy (2022)

  12. No Access

    Chapter

    Follow-Up During Treatment

    In the following section we discuss the rationale for a follow-up schedule for breast cancer patients during a radiation course, with regard to various treatment protocols.

    Orit Kaidar-Person, Philip Poortmans, Icro Meattini in Breast Cancer Radiation Therapy (2022)

  13. No Access

    Chapter

    General Management

    Substantial progress has been made in the conceptual approach and clinical management of breast cancer over the past decades. Over the last years, radiation oncology focussed a lot on the challenges related to...

    Riccardo Alberto Audisio, Philip Poortmans in Breast Cancer Radiation Therapy (2022)

  14. No Access

    Book

    Breast Cancer Radiation Therapy

    A Practical Guide for Technical Applications

    MD Orit Kaidar-Person, Icro Meattini (2022)

  15. Article

    Open Access

    Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

    Residual breast cancer after neo-adjuvant chemotherapy (NACT) predicts disease outcome and is a surrogate for survival in aggressive breast cancer (BC) subtypes. Pathological complete response (pCR) rate, howe...

    Alex De Caluwé, Laurence Buisseret, Philip Poortmans, Dirk Van Gestel in BMC Cancer (2021)

  16. No Access

    Article

    Spatial location of local recurrences after mastectomy: a systematic review

    We performed a systematic review to document the spatial location of local recurrences (LR) after mastectomy.

    Orit Kaidar-Person, Philip Poortmans in Breast Cancer Research and Treatment (2020)

  17. No Access

    Chapter

    T-Staging and Target Volume Definition by Imaging in Breast Tumours

    Breast cancer is the most frequent cancer in women in both developed and develo** countries. Early detection of breast cancer is of great importance, as it allows carrying out less mutilating or aggressive t...

    Roberto C. Delgado Bolton in Imaging and Interventional Radiology for R… (2020)

  18. Article

    Open Access

    Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study

    Preoperative chemoradiation therapy (CRT) may induce downstaging in rectal cancer (RC). Short-course radiation therapy (SC-RT) with immediate surgery does not cause substantial downstaging. However, the TNM cl...

    Steven L. Bosch, Rob H. A. Verhoeven, Valery E. P. P. Lemmens in Virchows Archiv (2019)

  19. No Access

    Article

    When Can We Avoid Postmastectomy Radiation Following Primary Systemic Therapy?

    Postmastectomy radiation therapy (PMRT) has been shown to reduce the risk of locoregional recurrences (LRR) and of distant metastases (DM) and to improve breast cancer–specific survival (BCSS) as well as overa...

    Ángel Montero, Raquel Ciérvide, Philip Poortmans in Current Oncology Reports (2019)

  20. No Access

    Article

    Breast cancer

    Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with distant organ metastases is consider...

    Nadia Harbeck, Frédérique Penault-Llorca, Javier Cortes in Nature Reviews Disease Primers (2019)

previous disabled Page of 2